OM5A Stock Overview
Engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Observe Medical ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.028 |
| 52 Week High | NOK 0.047 |
| 52 Week Low | NOK 0.0021 |
| Beta | 0.39 |
| 11 Month Change | -1.43% |
| 3 Month Change | -12.10% |
| 1 Year Change | -22.47% |
| 33 Year Change | -98.39% |
| 5 Year Change | -96.85% |
| Change since IPO | -95.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| OM5A | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 21.1% | -2.5% | -1.3% |
| 1Y | -22.5% | -8.4% | 7.4% |
Return vs Industry: OM5A underperformed the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: OM5A underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| OM5A volatility | |
|---|---|
| OM5A Average Weekly Movement | 11.7% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: OM5A's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: OM5A's weekly volatility has decreased from 104% to 12% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 9 | Jorgen Mann | observemedical.com |
Observe Medical ASA engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and video for nurses and medical staff. The company also offers Unometer, Safeti Plus, Unometer 500, UnoMeter, and AbdoPressure products used for drainage, collection, and measurement of urine output from patients, as well as provides medtech devices and disposables within urine measurement, anesthesiology/ICUs, and wound care products.
Observe Medical ASA Fundamentals Summary
| OM5A fundamental statistics | |
|---|---|
| Market cap | €7.71m |
| Earnings (TTM) | -€4.11m |
| Revenue (TTM) | €2.52m |
3.1x
P/S Ratio-1.9x
P/E RatioIs OM5A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OM5A income statement (TTM) | |
|---|---|
| Revenue | NOK 29.18m |
| Cost of Revenue | NOK 19.18m |
| Gross Profit | NOK 10.00m |
| Other Expenses | NOK 57.68m |
| Earnings | -NOK 47.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 34.26% |
| Net Profit Margin | -163.41% |
| Debt/Equity Ratio | 52.1% |
How did OM5A perform over the long term?
See historical performance and comparison